BR9807299A - Vacina contra bursite infecciosa - Google Patents

Vacina contra bursite infecciosa

Info

Publication number
BR9807299A
BR9807299A BR9807299-4A BR9807299A BR9807299A BR 9807299 A BR9807299 A BR 9807299A BR 9807299 A BR9807299 A BR 9807299A BR 9807299 A BR9807299 A BR 9807299A
Authority
BR
Brazil
Prior art keywords
vaccine
infectious
infectious bursitis
pouch
size
Prior art date
Application number
BR9807299-4A
Other languages
English (en)
Other versions
BR9807299B1 (pt
Inventor
Frans Gerrrit Davelaar
Bernarda Johanna Pitstra
Nico Van Wiltenburg
Original Assignee
Dimminaco Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dimminaco Ag filed Critical Dimminaco Ag
Publication of BR9807299A publication Critical patent/BR9807299A/pt
Publication of BR9807299B1 publication Critical patent/BR9807299B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Patente de Invenção:<B>"VACINA CONTRA BURSITE INFECCIOSA"<D>. A presente invenção refere-se a uma vacina que é capaz de proteger aves domésticas contra infecções de bursite infecciosa, caracterizada pelo fato de que ela contém um vírus de bursite infecciosa que tem as propriedades combinadas quando da administração a uma galinha causando uma redução no tamanho do tamanho da bolsa, expresso como razão em peso bolsa/corpo, de menos de 55% e a capacidade de proteger as aves domésticas tendo um trato de anticorpo ELISA de pelo menos cerca de 500 e com vírus tendo as características acima.
BRPI9807299-4A 1997-02-03 1998-01-29 vacina contra bursite infecciosa. BR9807299B1 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97200298A EP0861665A1 (en) 1997-02-03 1997-02-03 Infectious bursitis vaccine

Publications (2)

Publication Number Publication Date
BR9807299A true BR9807299A (pt) 2000-04-18
BR9807299B1 BR9807299B1 (pt) 2009-01-13

Family

ID=8227982

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9807299-4A BR9807299B1 (pt) 1997-02-03 1998-01-29 vacina contra bursite infecciosa.

Country Status (18)

Country Link
US (1) US7211260B1 (pt)
EP (2) EP0861665A1 (pt)
JP (1) JP2001511138A (pt)
KR (1) KR100545462B1 (pt)
CN (1) CN1178697C (pt)
AR (1) AR011108A1 (pt)
AT (1) ATE333894T1 (pt)
AU (1) AU745477B2 (pt)
BR (1) BR9807299B1 (pt)
CA (1) CA2278824A1 (pt)
CO (1) CO4790102A1 (pt)
DE (1) DE69835346T2 (pt)
ES (1) ES2268766T3 (pt)
HK (1) HK1024411A1 (pt)
IL (1) IL130832A (pt)
NZ (1) NZ336937A (pt)
WO (1) WO1998033522A1 (pt)
ZA (1) ZA98830B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0861665A1 (en) 1997-02-03 1998-09-02 Dimminaco Ag/Sa/Ltd. Infectious bursitis vaccine
ZA200104596B (en) 2000-06-09 2001-12-06 Akzo Nobel Nv IBDV strain for in ovo administration.
EP1161953A3 (en) * 2000-06-09 2004-02-04 Akzo Nobel N.V. IBDV strain for in OVO administration
ES2310062B1 (es) 2005-07-15 2009-11-13 Bionostra, S.L. Particulas pseudovirales vacias quimericas derivadas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), procedimiento de obtencion y aplicaciones.
KR101560793B1 (ko) 2013-08-20 2015-10-15 주식회사 바이오포아 비병원성 전염성낭병 변이 바이러스 및 이의 백신으로써의 용도

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4530831A (en) * 1982-11-02 1985-07-23 Akzo N.V. Infectious Bursal Disease vaccine
US4824668A (en) * 1987-03-09 1989-04-25 Sterwin Laboratories Inc. Attenuated infectious bursal disease virus strain and vaccine therefrom
US5192539A (en) * 1988-07-21 1993-03-09 Akzo N.V. Infectious bursal disease virus production in continuous cell lines
NZ235474A (en) * 1989-10-18 1992-12-23 Univ Maryland Virus capable of inducing infectious bursal disease; assay and vaccine
IL103939A (en) * 1992-12-01 1996-09-12 Abic Ltd An anti-DBI vaccine in birds containing attenuated live DBI virus
EP0861665A1 (en) 1997-02-03 1998-09-02 Dimminaco Ag/Sa/Ltd. Infectious bursitis vaccine

Also Published As

Publication number Publication date
AU745477B2 (en) 2002-03-21
BR9807299B1 (pt) 2009-01-13
DE69835346D1 (de) 2006-09-07
AU6294098A (en) 1998-08-25
CO4790102A1 (es) 1999-05-31
CN1246800A (zh) 2000-03-08
DE69835346T2 (de) 2006-11-23
HK1024411A1 (en) 2000-10-13
IL130832A (en) 2005-03-20
KR100545462B1 (ko) 2006-01-24
ZA98830B (en) 1999-08-02
EP0967991B1 (en) 2006-07-26
ATE333894T1 (de) 2006-08-15
EP0967991A1 (en) 2000-01-05
KR20000070736A (ko) 2000-11-25
IL130832A0 (en) 2001-01-28
CA2278824A1 (en) 1998-08-06
EP0861665A1 (en) 1998-09-02
CN1178697C (zh) 2004-12-08
JP2001511138A (ja) 2001-08-07
NZ336937A (en) 2001-10-26
US7211260B1 (en) 2007-05-01
AR011108A1 (es) 2000-08-02
WO1998033522A1 (en) 1998-08-06
ES2268766T3 (es) 2007-03-16

Similar Documents

Publication Publication Date Title
MY141594A (en) 3&#39;-PRODRUGS OF 2&#39;-DEOXY-ß-L-NUCLEOSIDES
BR9912410A (pt) Vacina para imunização de aves, e, processos para imunizar uma ave e para preparar uma vacina para imunizar uma ave
BR0208183A (pt) Peptìdeo modificado por wt1
BR9913681A (pt) Composição farmacêutica compreendendo entacapona ou nitecapona, assim como um derivado de celulose reticulada
BR0214254A (pt) Pó filmogênio micronizado e composição farmacêutica, cosmética ou neutracêutica
ATE295180T1 (de) Zubereitung zur immunisierung gegen den aids- virus
BR0212374A (pt) Oxintomodulina para a prevenção ou para o tratamento do excesso de peso
JP2008528512A5 (pt)
RS20050066A (en) Aqueous 2,6-diisopropylphenol pharmaceutical compositions
BR9810658A (pt) Composições farmacêuticas contendo hemissulfato de eletriptano e cafeìna.
BR9807299A (pt) Vacina contra bursite infecciosa
BR0013625A (pt) Composição para uso no tratamento de carcinoma hepatocelular
BR9915429A (pt) Haste de tampão.
BR0109139A (pt) Composições farmacêuticas incluindo alginatos
BR0011261A (pt) Composição oral compreendendo perlita, e, uso de perlita
BR0102940A (pt) Agente para o tratamento de doença de parkinson compreendendo um agente de melhora da função de astrócitos como ingrediente ativo
Norton et al. Administration of dehydroepiandrosterone sulfate retards onset but not progression of autoimmune disease in NZB/W mice
BRPI0713278A2 (pt) agente profilÁtico ou terapÊutico para doenÇa viral
NZ228232A (en) Live combined vaccine comprising at least one live infectious bronchitis virus and at least one other virus infectious to poultry
CO5170447A1 (es) Derivado de benzamida y medicamento que lo contiene
TR200202169T1 (tr) Tanı ve tedavide kullanım için pürifiye hepatit C virüsü zarf proteinleri.
ES2160927T3 (es) Composiciones farmaceuticas que comprenden interferon alfa humano natural.
WO2004039402A3 (es) Prevención y tratamiento del síndrome respiratorio y reproductivo del cerdo con el uso de immunoglobulinas obtenidas de la yema de huevo proveniente de gallinas hiperinmunizadas con el virus de prrs
KR940002268A (ko) 21-클로로-프레그난 유도체
ATE234861T1 (de) Influenzaimpfstoff, der als sinergistischer zusatzmittel influenzavirusinnenkörper enthält

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 07/04/2009, OBSERVADAS AS CONDICOES LEGAIS.

B24H Lapse because of non-payment of annual fees (definitively: art 78 iv lpi)
B24F Patent annual fee: publication cancelled

Free format text: ANULADA A PUBLICACAO CODIGO 24.8 NA RPI NO 2259 DE 22/04/2014 POR TER SIDO INDEVIDA.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE AS 14A, 15A, 16A, 17A, 18A, 19A, 20A, 21A E 22A ANUIDADES.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2607 DE 22-12-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.